Basit öğe kaydını göster

dc.contributor.authorBulcun, Emel
dc.contributor.authorEkici, Mehmet
dc.contributor.authorEkici, Aydanur
dc.contributor.authorKısa, Üçler
dc.date.accessioned2020-06-25T18:07:22Z
dc.date.available2020-06-25T18:07:22Z
dc.date.issued2013
dc.identifier.citationclosedAccessen_US
dc.identifier.issn1541-2555
dc.identifier.issn1541-2563
dc.identifier.urihttps://doi.org/10.3109/15412555.2012.735292
dc.identifier.urihttps://hdl.handle.net/20.500.12587/5557
dc.descriptionKISA, Ucler/0000-0002-8131-6810en_US
dc.descriptionWOS: 000316954500010en_US
dc.descriptionPubMed: 23547630en_US
dc.description.abstractBackground: Microalbuminuria is an important risk factor for cardiovascular diseases. Microalbuminuria may be seen due to hypoxemia in patients with chronic obstructive pulmonary disease (COPD). Objectives: In this study, we investigated prevalence and relationship of microalbuminuria with clinical and physiological parameters in patients with COPD. Method: During the research, 66 consecutive patients with COPD and 40 cases smokers with normal spirometry were included. The urinary albumin creatinin ratio (UACR) was calculated according to previously described formula. The presence of microalbuminuria was defined as UACR being >= 20 in men and >= 30 in women. The severity index of chronic diseases was evaluated by using MCIRS. Results: The rate of presence of microalbuminuria and UACR were higher in patients with COPD than smokers with normal spirometry. Pearson correlation analysis showed a significant inverse relationship between UACR and PaO2, FEV1%, FVC%. On the other hand, there was a positive relationship between UACR and BODE index. There was a significant relationship between the presence of microalbuminuria with PaO2 and BODE index. In the linear regression model, there was a negative relationship between UARC and PaO2 yet there was a significantly positive relationship between UARC and MCIRS score, BODE index. In the logistic regression model, the presence of microalbuminuria showed significant associations with PaO2, BODE index. Conclusion: Microalbuminuria may be seen in patients with COPD, depending on the severity of disease and hypoxemia. Microalbuminuria in patients with severe COPD should be examined in regular periods for risk of cardiovascular morbidity or mortality.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Incen_US
dc.relation.isversionof10.3109/15412555.2012.735292en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChronic Obstructive Pulmonary Diseaseen_US
dc.subjecthHypoxemiaen_US
dc.subjectmMicroalbuminuriaen_US
dc.titleMicroalbuminuria in Chronic Obstructive Pulmonary Diseaseen_US
dc.typearticleen_US
dc.contributor.departmentKırıkkale Üniversitesien_US
dc.identifier.volume10en_US
dc.identifier.issue2en_US
dc.identifier.startpage186en_US
dc.identifier.endpage192en_US
dc.relation.journalCopd-Journal Of Chronic Obstructive Pulmonary Diseaseen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster